5 drug(s) with this reaction
16,649 total reports
Accidental Exposure To Product has been reported as an adverse reaction across 5 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 16,649 adverse event reports mention accidental exposure to product in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with accidental exposure to product, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have accidental exposure to product listed in their FDA adverse event reports, sorted by report count:
In addition to accidental exposure to product, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
5 drug(s) manufactured by Amgen Inc have accidental exposure to product listed in their FDA adverse event reports: ERENUMAB-AOOE, PEGFILGRASTIM, DENOSUMAB, BLINATUMOMAB, ROMOSOZUMAB-AQQG.
There are a combined 16,649 reports of accidental exposure to product across 5 Amgen Inc drug(s) in the FDA adverse event database.